Evidence for altered hepatic gluconeogenesis in patients with cirrhosis using in vivo 31-phosphorus magnetic resonance spectroscopy

Gut

Volumn 49, Issue 4, 2001, Pages 557-564

  Changani, K K ^a   Jalan, R ^a,c   Cox, I J ^a   Ala Korpela, M ^a   Bhakoo, K ^b   Taylor Robinson, S D ^a   Bell, J D ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Alanine; Ammonia; Cirrhosis; Glucagon; Gluconeogenesis

Indexed keywords

ALANINE; AMMONIA; ESTER; GLUCAGON; PHOSPHATE; PHOSPHORUS 31;

ADULT; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GLUCONEOGENESIS; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LIVER CIRRHOSIS; METABOLISM; METABOLITE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SPECTROSCOPY;

ADULT; ALANINE; ANALYSIS OF VARIANCE; AREA UNDER CURVE; CASE-CONTROL STUDIES; FOURIER ANALYSIS; GLUCONEOGENESIS; HUMANS; LIVER CIRRHOSIS; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; PHOSPHORIC ACIDS; PHOSPHORUS; STATISTICS, NONPARAMETRIC;

EID: 0034822681     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.49.4.557     Document Type: Article

References (34)

1. Disordered energy and protein metabolism in liver disease
2. Decreased hepatic glycogen content and accelerated response to starvation in rats with carbon tetrachloride-induced cirrhosis
3. Energy metabolism in patients with acute and chronic liver disease
4. Energy expenditure and substrate oxidation in patients with cirrhosis: The impact of cause, clinical staging and nutritional state
5. Is hepatic glycogen content a regulator of glucose secretion?
6. Contributions of net hepatic glycogenolysis and gluconeogenesis to glucose production
7. Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect
8. Quantification of gluconeogenesis in cirrhosis: Response to glucagon
9. 31P nuclear magnetic resonance spectra of normal human liver: Towards biochemical pathology in vivo
10. 31P nuclear magnetic resonance study
11. Carbohydrate metabolism of the perfused rat liver
12. 31P MRS in the rat
13. Altered hepatic gluconeogenesis during L-alanine infusion in weight-losing lung cancer patients as observed by phosphorus magnetic resonance spectroscopy and turnover measurements
14. Transection of the oesophagus for bleeding oesophageal varices
15. Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques
16. Effect of functional grade and aetiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: Biochemical basis of spectral appearances
17. 1H NMR-based absolute quantitation of human lipoproteins and their lipid contents directly from plasma
18. 31P NMR ex vivo pig liver studies
19. A knowledge-based approach to minimize baseline roll in chemical shift imaging
20. Cerebral proton and phosphorus-31 magnetic resonance spectroscopy in patients with subclinical hepatic encephalopathy
21. In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts
22. 1H NMR investigation in vitro of normal and abnormal human liver
23. Phospholipid metabolites as indicators of cancer cell function
24. 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver
25. Decreased energy and phosphorylation status in the liver of lung cancer patients with weight loss
26. 31P magnetic resonance spectroscopy in vivo
27. Intravenous intralipid infusion in hepatic steatosis: An in vivo hepatic phosphorus-31 magnetic resonance spectroscopy study
28. Glucagon and insulin metabolism in cirrhotic patients
29. Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation
30. Effects of intravenous infusion of 17 amino acids on the secretion of GH, glucagon, and insulin in sheep
31. Effects of epinephrine on glucose metabolism in patients with alcoholic cirrhosis
32. Effects of branched-chain-enriched amino acid solution on insulin and glucagon secretion and blood glucose level in liver cirrhosis
33. Unresponsiveness of hepatic nitrogen metabolism to glucagon infusion in patients with cirrhosis: Dependence on liver cell failure
34. The relative effects of enterically administered plasma and packed cells on circulating blood ammonia